$27.49
Price
$2.8B
Market Cap
—
P/E Ratio
-6.0
Forward P/E
$-4.41
EPS (TTM)
—
Dividend Yield
$1.1B
Cash
$161M
Total Debt
101M
Shares Out
$13.53
$36.44
52-Week Range
Institutional Ownership of BEAM THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for BEAM THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | NEW | 9.1K | $221658 | $19.94 | |
Insider Trading for BEAM THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $1.5M
0
Buys
7
Sells
-1.5M
Net
2
Grants
Largest
$616K
Evans
$613K
Evans
$171K
Emany
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | Amy Simon | Chief Medical Officer | GRANT | 12.5K | — | — |
| Dec 31, 2025 | Christine Bellon | Chief Legal Officer | SELL | 1.3K | $27.10 | $34K |
| Dec 31, 2025 | Sravan Kumar Emany | Chief Financial Officer | SELL | 6.3K | $27.10 | $171K |
| Oct 27, 2025 | FMR LLC | 10% Owner | SELL | 459 | $26.68 | $12K |
| Oct 06, 2025 | FMR LLC | 10% Owner | GRANT | 1.23M | — | — |
| Oct 02, 2025 | John M. Evans | CEO | EXERCISE | 25.0K | $0.67 | $17K |
| Oct 02, 2025 | John M. Evans | CEO | SELL | 25.0K | $24.63 | $616K |
| Oct 01, 2025 | Christine Bellon | Chief Legal Officer | SELL | 373 | $24.53 | $9K |
| Oct 01, 2025 | John M. Evans | CEO | EXERCISE | 25.0K | $0.67 | $17K |
| Oct 01, 2025 | John M. Evans | CEO | SELL | 25.0K | $24.51 | $613K |
| Oct 01, 2025 | Bethany J Cavanagh | SVP, Finance and Treasurer | SELL | 467 | $24.53 | $11K |